Search
Search
€

Or 34,00€ After 66% tax deduction

I make a monthly donation I make an IFI donation

Paris Brain Institute

is a leading scientific and medical research center dedicated to the study of the brain and the discovery of new treatments for diseases of the nervous system. 

Learn more
Scroll

Video Neurofocus: the CaCovi Project on Epilepsy and Schizophrenia

Discover the CaCovi project, which has shown that brain activity is regulated by inhibitory neurons called "basket cells", endowed with receptors sensitive to endogenous cannabinoids, opening up therapeutic prospects for pathologies such as epilepsy, schizophrenia and anxiety.

Watch the video
Projet CaCovi

Our latest news

Cerveau modélisé
Paris Brain Institute Call for Junior Group Leaders in Artificial Intelligence and Data Science
The Paris Brain Institute is launching a Call for Junior Group Leaders, inviting outstanding early-career scientists in artificial intelligence, data science, computational neuroscience, and related fields to establish their own independent research...
02.11.2026 Institutional
World Brain Health Forum 2026 Vignette
World Brain Health Forum 2026: placing brain health at the heart of global priorities
In January 2026, Paris became the stage for a major shift in the way brain health is addressed worldwide. Held as part of the 15th anniversary of the Paris Brain Institute, the World Brain Health Forum 2026 brought together 80 international speakers...
01.30.2026 Events
Lancement d’un programme mondial pour la santé cérébrale
Inaugural Global Brain Care Scholars Program
The Ban Ki-moon Foundation, the Paris Brain Institute, and the Vascular Brain Health Institute signed a new partnership agreement marking a major step to championing brain health, building local capacity, and specialized education to launch the...
01.29.2026 Institutional
Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
See all our news
Des mains de chercheuse qui manipulent

Research at Paris Brain Institute

Since its creation, Paris Brain Institute has placed patients at the heart of its scientific and medical strategy.

  • 878 Staff

    including 84% scientific, medical and paramedical staff (as at September 30, 2024)

  • 29 Research teams

    selected by a Scientific Advisory Board

  • 51 Nationalities

    (as at September 30, 2024)

  • 12 Technical facilities

    and biobank

Find out more

Understanding the brain

Le fonctionnement du cerveau : deux scientifiques regardent des images de cerveau
Understanding the Brain
Every day, scientific research tells us a little more about the brain, the body’s control room for all cognition, memory and emotions. From the anatomy of the brain to the latest knowledge about consciousness and the different neurological diseases...
Imagerie cérébrale Lubetzki Stankoff
Alzheimer's disease
With longer life expectancies and the biological mechanisms at the origin of neurodegenerative diseases becoming increasingly complex, it is now estimated that, in France in 2020, 1.3 million people were affected by Alzheimer’s disease. Today, more...
Imagerie cérébrale Corti Corvol Parkinson
Parkinson's disease
Parkinson’s disease is the second-most common neurodegenerative condition after Alzheimer’s disease, and the main cause of Parkinsonian syndrome.
Imagerie scientifique équipe Boilée
Lou Gerhig’s disease or amyotrophic lateral sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS), or ‘Lou Gerhig’s disease’, is a progressive and fatal neuromuscular condition involving the gradual death of motor neurons, the neurons that control walking, speech, swallowing and breathing. This loss of motor...
Imagerie médicale Baulac
Epilepsy
The word ‘epilepsy’ originates from a Greek word meaning ‘to seize’, reflecting the sudden and unpredictable onset of seizures. In France, 600,000 people are affected by this chronic neurological disease, which can present with different symptoms...
Visages bleus
Depression
Mental health, an essential component of our overall health, is a state of well-being, and an ability of the mind to function normally and respond appropriately to environmental stimuli. Mental disorders occur when this state of well-being is...
Discover all our ressources

How support Paris Brain Institute?

And commit to it